Verification evidence is still being completed.
PDF / print export
Bioton
Warsaw, Poland
- Verified lead
- Jeremy Launders
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO and President of the Management Board
- 2026 technical specialization
- Insulin, Diabetes Therapeutics, Biomanufacturing, Pharmaceutical Production, and Biopharma
- Review cycle
- May 2026
- Full address
- ul. Staroscinska 5, 02-516 Warszawa, Poland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official BIOTON contact page confirming the Warsaw registered office.
- Editorial note
- Bioton is published because official company materials confirm current leadership, Warsaw corporate address, and a real biomanufacturing footprint in Poland.
Insulin, Diabetes Therapeutics, Biomanufacturing, Pharmaceutical Production, and Biopharma
Official leadership disclosure, Official Warsaw office disclosure, Biomanufacturing platform claim
Bioton is published because official company materials confirm current leadership, Warsaw corporate address, and a real biomanufacturing footprint in Poland.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Warsaw, Poland
Bioton
Insulin, Diabetes Therapeutics, Biomanufacturing, Pharmaceutical Production, and Biopharma · Commercial biomanufacturing footprint
Bioton runs insulin manufacturing, biopharmaceutical production, and diabetes therapeutics operations in Warsaw, Poland.
- Lead
- Jeremy Launders (verified ↗)
- Address
- ul. Staroscinska 5, 02-516 Warszawa, Poland (source ↗)
- Compliance
- GMP
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Commercial biomanufacturing footprint
- Capabilities
- Insulin Manufacturing · Biopharmaceutical Production · Diabetes Therapeutics Operations
- Founded
- 1989
- Headcount
- 1001-5000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Jeremy Launders
CEO and President of the Management Board
Full addressul. Staroscinska 5, 02-516 Warszawa, Poland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Commercial biomanufacturing footprint
Warsaw, Poland. Insulin, Diabetes Therapeutics, Biomanufacturing, Pharmaceutical Production, and Biopharma. Review completed on 22 Mar 2026.
Polish pharmaceutical manufacturing oversight
Official leadership disclosure, Official Warsaw office disclosure, Biomanufacturing platform claim
Insulin, Diabetes Therapeutics, Biomanufacturing, Pharmaceutical Production, and Biopharma
Bioton is published because official company materials confirm current leadership, Warsaw corporate address, and a real biomanufacturing footprint in Poland.
Editorial note
Bioton is published because official company materials confirm current leadership, Warsaw corporate address, and a real biomanufacturing footprint in Poland.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Insulin Manufacturing
Biopharmaceutical Production
Diabetes Therapeutics Operations
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Biopharma production lines
Insulin manufacturing workflow
Industrial quality systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Bioton located?
- Bioton operates from ul. Staroscinska 5, 02-516 Warszawa, Poland, Warsaw, Poland.
- Who runs Bioton?
- Bioton is led by Jeremy Launders, CEO and President of the Management Board. Verified 22 Mar 2026.
- What does Bioton do?
- Bioton runs insulin manufacturing, biopharmaceutical production, and diabetes therapeutics operations in Warsaw, Poland. Core capabilities: Insulin Manufacturing, Biopharmaceutical Production, Diabetes Therapeutics Operations.
Editorial context
Related technical briefs
Briefs that name Warsaw as a covered market or city.